Transactions
1
Insider / INSMED Inc
SCHAFER CAROL
Director at INSMED Inc
- Company
- INSMED Inc
- Ticker
- INSM
- First filing on record
- May 15, 2026
- Latest trade on record
- May 13, 2026
- SEC filings
- EDGAR ↗
SCHAFER CAROL, Director at INSMED Inc, has disclosed 1 transaction in INSM since May 15, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed May 15, 2026, 2 days after the trade.
Open-market buys
0
Sales
0
Avg. disclosure lag
2.0d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months SCHAFER CAROL reported 1 transaction that was neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 1 | 3,305 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 1 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| INSM | Other A | May 13, 2026 | May 15, 2026 | 2d | 3,305 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 15, 2026 | Form 4 | 0001272181-26-000004 | 1 | published | EDGAR ↗ |
Other insiders at INSMED Inc
- Lewis William Chair and CEO 136 rows
- Flammer Martina M.D. Chief Medical Officer 67 rows
- Smith Michael Alexander Chief Legal Officer 30 rows
- Adsett Roger Chief Operating Officer 20 rows
- Schaeffer Orlov S Nicole Chief People Strategy Officer 15 rows
- Bonstein Sara Chief Financial Officer 10 rows
- SHAROKY MELVIN MD Director 9 rows
- LEE LEO Director 6 rows
- Brennan David R Director 5 rows
- ANDERSON ELIZABETH M Director 3 rows
Everyone on file, with contracts and lobbying under the company's name: INSMED Inc.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 1 | May 15, 2026 | May 15, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.